Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|August 22, 2022
Overcoming tumor resistance mechanisms in CAR-NK cell therapyAntonio Valeri, Almudena García-Ortiz, Eva Castellano, et al.
Blood|September 25, 2008
In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1Paula Río, Néstor W Meza, Africa González-Murillo, et al.
Human Gene Therapy|December 17, 2009
Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemiaAfrica González-Murillo, M Luz Lozano, Lara Alvarez, et al.
Molecular Cancer Therapeutics|May 17, 2008
Relevance of the Fanconi anemia pathway in the response of human cells to trabectedinJosé A Casado, Paula Río, Esther Marco, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2005
Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cellsNiklas Feldhahn, Paula Río, Bonaventure Ndikung Bejeng Soh, et al.
Blood|August 30, 2002
In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout micePaula Río, José Carlos Segovia, Helmut Hanenberg, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type ICristina Mesa-Núñez, Carlos Damián, María Fernández-García, et al.
Scientific Reports|April 26, 2020
TALEN mediated gene editing in a mouse model of Fanconi anemiaMaria José Pino-Barrio, Yari Giménez, Mariela Villanueva, et al.
Plos One|March 3, 2012
Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinaseÁlvaro Cuesta-Domínguez, Mara Ortega, Cristina Ormazábal, et al.
Pageof 5